STAAB THOMAS R II has filed 15 insider transactions across 2 companies since January 2023.
Most recent transaction: a grant/award of 450000 shares of TENAX THERAPEUTICS, INC. ($TENX) on May 11, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | TENAX THERAPEUTICS, INC. | $TENX | STAAB THOMAS R II | Chief Financial Officer | A | Stock Option (right to buy) | 450000 | $0.00 | 450,000.0000 | 39,741,404 | 9999.99% | 1.13% |
| May 11, 2026 | TENAX THERAPEUTICS, INC. | $TENX | STAAB THOMAS R II | Chief Financial Officer | A | Common Stock | 10000 | $0.00 | 10,000.0000 | 39,741,404 | 9999.99% | 0.03% |
| May 6, 2026 | LENSAR, Inc. | $LNSR | STAAB THOMAS R II | Chief Financial Officer | F | Common Stock | 1350 | $5.39 | 174,609.0000 | 12,044,000 | 0.77% | 0.01% |
| March 19, 2026 | LENSAR, Inc. | $LNSR | STAAB THOMAS R II | Chief Financial Officer | M | Stock Option (Right to Buy) | 5500 | $0.00 | 14,295.0000 | 12,044,000 | 27.78% | 0.05% |
| March 19, 2026 | LENSAR, Inc. | $LNSR | STAAB THOMAS R II | Chief Financial Officer | M | Common Stock | 5500 | $2.65 | 175,959.0000 | 12,044,000 | 3.23% | 0.05% |
| Feb. 18, 2026 | LENSAR, Inc. | $LNSR | STAAB THOMAS R II | Chief Financial Officer | F | Common Stock | 1076 | $11.32 | 170,459.0000 | 12,044,000 | 0.63% | 0.01% |
| Jan. 11, 2026 | LENSAR, Inc. | $LNSR | STAAB THOMAS R II | Chief Financial Officer | F | Common Stock | 1826 | $11.57 | 171,535.0000 | 12,044,000 | 1.05% | 0.02% |
| Feb. 18, 2025 | LENSAR, Inc. | $LNSR | STAAB THOMAS R II | Chief Financial Officer | A | Common Stock | 12766 | $0.00 | 173,361.0000 | 11,518,000 | 7.95% | 0.11% |
| Jan. 11, 2025 | LENSAR, Inc. | $LNSR | STAAB THOMAS R II | Chief Financial Officer | F | Common Stock | 1839 | $8.25 | 160,595.0000 | 11,518,000 | 1.13% | 0.02% |
| Aug. 8, 2024 | LENSAR, Inc. | $LNSR | STAAB THOMAS R II | Chief Financial Officer | M | Common Stock | 3500 | $2.65 | 162,434.0000 | 10,971,000 | 2.20% | 0.03% |
| Aug. 8, 2024 | LENSAR, Inc. | $LNSR | STAAB THOMAS R II | Chief Financial Officer | M | Stock Option (Right to Buy) | 3500 | $0.00 | 19,795.0000 | 10,971,000 | 15.02% | 0.03% |
| Jan. 11, 2024 | LENSAR, Inc. | $LNSR | STAAB THOMAS R II | Chief Financial Officer | F | Common Stock | 1853 | $4.43 | 139,934.0000 | 10,971,000 | 1.31% | 0.02% |
| May 6, 2024 | LENSAR, Inc. | $LNSR | STAAB THOMAS R II | Chief Financial Officer | A | Common Stock | 19000 | $0.00 | 158,934.0000 | 10,971,000 | 13.58% | 0.17% |
| Jan. 11, 2023 | LENSAR, Inc. | $LNSR | STAAB THOMAS R II | Chief Financial Officer | A | Common Stock | 6656 | $0.00 | 141,787.0000 | 0 | 4.93% | 0.00% |
| Jan. 11, 2023 | LENSAR, Inc. | $LNSR | STAAB THOMAS R II | Chief Financial Officer | A | Stock Option (Right to Buy) | 23295 | $0.00 | 23,295.0000 | 0 | 9999.99% | 0.00% |